Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Value-Added Services Driving Better Patient Outcomes
Avricore, through its HealthTab(TM) flagship offering, is bringing health diagnosis and treatment closer to people The point-of-care testing market, which Avricore is part of, shows incredible potential for growth in the coming years Strategic investments and critical partnerships with other key players in the industry have allowed Avricore to stand out among its competitors This has also enabled the company to create value for stakeholders and better outcomes for patients The point-of-care testing market is projected to be valued at $50.6 billion by 2025, up from $29.5 billion in 2020. This will represent a compounded annual growth rate (“CAGR”) of…